Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. - Wikidata - wikimedia - TriplyDB

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

http://www.wikidata.org/entity/Q35791328

about

A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors.Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan EZH2 depletion blocks the proliferation of colon cancer cells.Dystroglycan controls signaling of multiple hormones through modulation of STAT5 activity.Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring.Design and screening of a glial cell-specific, cell penetrating peptide for therapeutic applications in multiple sclerosis.Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival The dystroglycan complex: from biology to cancer.The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations.Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancer Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization.RETRACTED: Dystroglycan and perlecan provide a basal cue required for epithelial polarity during energetic stress.Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations.Exosomes as mediators of platinum resistance in ovarian cancer.The LKB1/AMPK polarity pathway.The secretome signature of colon cancer cell lines.Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer.Loss of dystroglycan function in oesophageal cancer.Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.Evolution on experimental animal model for upper urothelium carcinogenesis.γ-Secretase Dependent Nuclear Targeting of Dystroglycan.Expression of beta-dystroglycan is reduced or absent in many human carcinomas.Recent advancements in understanding mammalian O-mannosylation.Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells.Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis.Boundary cells restrict dystroglycan trafficking to control basement membrane sliding during tissue remodeling Actin-towards a deeper understanding of the relationship between tissue context, cellular function and tumorigenesis.Dystroglycan patterns on the prostate of non-obese diabetic mice submitted to glycaemic control.Differential expression of perlecan receptors, α-dystroglycan and integrin β1, before and after invasion of oral squamous cell carcinoma.Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement.Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy.

P2860

Q24314890-2692CC28-4A81-434F-91E3-BF125E272685 Q24604279-A68955DD-AE85-4415-830C-2AF5BD729FC7 Q33774186-91756151-2FFE-49B4-AC15-C6EFE1A485E1 Q33828666-34AD5F85-F7A4-4478-884C-6A0DA660A20D Q33963796-7C34A847-4E31-43DD-A5D0-B3121C4D5732 Q34240816-647E6EDF-D28F-4CD3-AC40-A36FF7A96BAD Q34377781-AC77F0EB-B3EC-42D0-B825-3B9D43D3D3CA Q34438165-BD6375AF-E612-41CA-9192-871C70E6FB6C Q35155971-57BB110B-0D93-4E88-9135-1B0872BC9552 Q35216105-EF4F8880-D8FC-4DE4-A211-0165F2AB7386 Q35899912-A6AE0103-F64C-481E-9D6D-7388AF1EEB8A Q35958353-53B49574-D17D-4A35-ABAA-35B71E9537BE Q36141779-736C0426-6426-4CD5-934D-5459CA3EA77D Q36214643-49E34459-AA26-445F-978B-00B7C872A275 Q36405312-969D0037-A5B5-47A8-9775-34926F972DB7 Q36523671-9F9D7A8C-E2EF-4CFA-86C6-67187D70DAB5 Q36561917-18A01EAA-BAB1-495E-BA98-84987D201F21 Q37160880-44B0197B-543D-4014-9DE6-8AD020AAFAC2 Q37296108-D753BF6F-35AF-4312-BD8A-7EA468F46DE2 Q37366097-DEF6832A-A5CB-4053-A49A-7F99DE390B16 Q37461242-FBBBF13B-B981-4325-84E4-7C60148C8367 Q37702112-2493F097-B067-40D2-B5D8-5DD26F58B3DA Q37707018-AB7D06DA-545D-4BE5-A708-5F2F9B1EFCC9 Q37824021-C29DB095-A296-45D8-83B5-3C397800A63B Q38489323-E7FE886F-9FCF-4882-BDA3-3531CF55A2B1 Q38493648-D9B30677-E46B-4BD2-8E9D-1E3E33A506BF Q39480902-089C5274-BD00-4EBB-B199-C2E1DCB412A2 Q39492998-9423650E-CF3A-4B88-9B77-8225A0B0644B Q39885213-D1A545E4-379D-48F4-B5D2-0353EEE1AA99 Q39909987-6DD81B71-3B7A-416E-BEA0-C7C3C6C1B634 Q39921521-10A25623-9FAB-4F2C-9788-AF1705BF2583 Q40092479-17861EC1-718A-4754-BF18-A47DB8A64FAF Q40129888-9F70A8EF-5332-41F2-A784-7276744583A9 Q40323008-FBF4DF8E-89E3-4F9B-BFD0-5B47E703FC59 Q41443201-155FACF2-7171-462E-9E9B-527E3619BFCB Q42037542-381B21CD-CB2F-487D-AE62-4771D23F7F09 Q42451626-D7255F30-0B4D-43F0-8D5D-6B6D9FBE2136 Q42482003-56195144-1744-4D36-8F8C-A5F8DAF2792C Q42494241-0F962355-C76C-4BD8-8D3E-26ED4A293DC6 Q42687793-9596C7C2-E17F-44AA-8E8E-91EB194C5225

P2860

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

http://www.wikidata.org/entity/Q35791328

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Dystroglycan expression is fre ...... ciated with tumor progression.

@ast

Dystroglycan expression is fre ...... ciated with tumor progression.

@en

type

label

Dystroglycan expression is fre ...... ciated with tumor progression.

@ast

Dystroglycan expression is fre ...... ciated with tumor progression.

@en

prefLabel

Dystroglycan expression is fre ...... ciated with tumor progression.

@ast

Dystroglycan expression is fre ...... ciated with tumor progression.

@en

P1433

Q35791328-04838883-D77B-4E47-9565-652F390A32A0

P1476

Q35791328-AECE7182-4596-4197-A9EF-0C532D1A7F03

P2093

Q35791328-02187B6A-A4B2-425B-9702-C43647BFC8B0

Q35791328-0945C2BD-BBFD-4A4C-AE13-3DEBCE4D34BF

Q35791328-0D6ED596-4422-4F35-A3D8-8C986E04B4A6

Q35791328-2FCC391D-57D1-4B23-AEBD-BCD8E15031DE

Q35791328-75807DCA-107D-4677-B3BF-633D3A6AF224

Q35791328-84845BBE-C3FB-44D3-808B-C3F66BBAB390

Q35791328-98919643-CDC7-4E9F-AEBB-F926E1996A1A

Q35791328-A394CEC0-92C0-4495-9597-8A365EAAF551

Q35791328-C9EA8F93-0445-4478-B603-F5D4E0CEB7E3

Q35791328-FCC0DA2C-BB6F-47D2-A3FA-285A4D277D35

P2860

Q35791328-1AB0F41F-99FB-48EE-987A-3277F67B5CB5

Q35791328-1C92ED32-60CC-406A-887F-29E101EB78DD

Q35791328-1DD4DE86-C0F7-42A5-959A-7155B5305A52

Q35791328-3991EED2-2821-4BDF-B6F6-9BC8D287C333

Q35791328-3D52C491-E8FF-4F0D-80C4-DAF35FDDE871

Q35791328-441DD7FD-28DF-4F3C-B355-3723B5271FDC

Q35791328-481B1655-1958-4B53-B2ED-76578A357F98

Q35791328-4B78EFE5-03AD-4804-BBB1-410560EAFED1

Q35791328-4F77E31A-A411-42A8-8DFA-58845A84F81C

Q35791328-508F950D-2609-4507-ACC5-FC2C8FB8A348

P304

Q35791328-822D7F6E-3B17-4948-A99A-C8D7FAA4570B

P31

Q35791328-C7653D17-E8A2-46F4-BF10-AEA8B25A8019

P356

Q35791328-CAA45D56-19C0-4CD7-96ED-3249755E04CF

P407

Q35791328-9C11078A-98A4-462D-9934-E5AEE537664A

P433

Q35791328-D77333B4-37DD-44FD-83BC-D7D3444C36EC

P478

Q35791328-210404C2-DAF6-4002-B4FA-B7D2C70EAF44

P50

Q35791328-66035B71-7C69-4F75-9BD4-DDA5BC3809C0

P577

Q35791328-63B5A3E1-701D-4330-9A9F-F5CE1ADD2E9C

P698

Q35791328-091B8AE5-978F-4634-A7AC-425798EB7983

P932

Q35791328-339B0837-0BC4-4C01-A25D-C75E14E6E5C5

P356

S0002-9440(10)63881-3

P1433

The American Journal of Pathology

P1476

Dystroglycan expression is fre ...... ociated with tumor progression

@en

P2093

Achille Cittadini

http://www.w3.org/2001/XMLSchema#string

Alessandro Sgambato

http://www.w3.org/2001/XMLSchema#string

Andrea Camerini

http://www.w3.org/2001/XMLSchema#string

Carmen Losasso

http://www.w3.org/2001/XMLSchema#string

Gian Paolo Trentini

http://www.w3.org/2001/XMLSchema#string

Giovanni Capelli

http://www.w3.org/2001/XMLSchema#string

Giulio Rossi

http://www.w3.org/2001/XMLSchema#string

Mario Migaldi

http://www.w3.org/2001/XMLSchema#string

Micaela Montanari

http://www.w3.org/2001/XMLSchema#string

Rodolfo Cangiano

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction

Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization

Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix

SH3 domain-mediated interaction of dystroglycan and Grb2

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Distribution of dystroglycan in normal adult mouse tissues

Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice

The Grb2 adaptor.

Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan.

P304

849-860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63881-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P50

Andrea Brancaccio

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12598319

http://www.w3.org/2001/XMLSchema#string

P932

1868099

http://www.w3.org/2001/XMLSchema#string